Balthaser Kevin sold ACRS
December 31, 2025 · Form 4 insider transaction
Balthaser Kevin sold 19,934 shares of Aclaris Therapeutics, Inc. at $3.01 per share, a transaction worth $60.0K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
19,934
Price
$3.01
Total value
$60.0K
InsiderBalthaser Kevin
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after146,424
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.